Proneural GBM is characterized by alterations of PDGFRA and mutations in IDH1 and TP53, sharing gene expression features with low-grade gliomas and secondary GBM (i.e., low-grade gliomas later recurred as GBM). Here, PDGFRA is linked to central nervous system cancer.